Group 1 - FMR LLC reduced its stake in Emerging Optical (00125) by 860,000 shares at a price of HKD 0.4138 per share, totaling approximately HKD 355,900 [1] - After the reduction, FMR LLC's remaining shareholding is approximately 20.616 million shares, representing a holding percentage of 7.85% [1]

Group 1 - FMR LLC increased its stake in China Life from 5.93% to 6.10% as of May 28 [1] - The average share price for this transaction was 16.0235 HKD [1]

Company Overview - IBA (Ion Beam Applications) is the world's leading provider of proton therapy solutions for cancer treatment, specializing in particle accelerator technology and advanced radiation therapy [11] - The company is based in Louvain-la-Neuve, Belgium, and employs approximately 2,100 people globally [11] - IBA is listed on the pan-European stock exchange EURONEXT [12] Shareholding Notification - FMR LLC issued a transparency notification regarding a change in voting rights, indicating that Fidelity Management & Research Company LLC crossed downwards the 1% threshold on April 3, 2025 [2][10] - Following the transaction, Fidelity Management & Research Company LLC holds 397,873 voting rights, representing 0.98% of the total voting rights [5] - The total voting rights held by all entities under FMR LLC amount to 579,650, which is 1.43% of the total [5][6] Controlled Undertakings - The chain of controlled undertakings includes FIAM LLC, which is controlled by FIAM Holdings LLC, and FMR Investment Management (UK) Limited, controlled by Fidelity Management & Research Company LLC [8] - FMR LLC is the parent company and is not a controlled undertaking [8] Investment Management - The holdings attributed to the entities mentioned arise from various collective investment undertakings managed by FIAM LLC, FMR Investment Management (UK) Limited, and Fidelity Management & Research Company LLC [9] - These entities act as discretionary investment managers and exercise voting rights at their discretion in the absence of specific instructions [9]